Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response

BackgroundNeoadjuvant immunochemotherapy (NICT) is increasingly used in patients with locally advanced resectable esophageal squamous cell carcinoma (ESCC). However, optimal postoperative adjuvant treatment strategies remain unclear. This study aimed to evaluate the efficacy of immunotherapy-based a...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Chenyu Wang, Xiaoran Geng, Xinyu Cheng, Runchuan Ren, Linzhi Jin, Zhaojie Sheng, Shenglei Li, Meiling Zang, Yaowen Zhang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2026-06-01
Cyfres:	Frontiers in Immunology
Pynciau:	esophageal squamous cell carcinoma immunotherapy-based adjuvant treatment neoadjuvant immunochemotherapy pathological complete response pathological downstaging
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1802037/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!